These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19397896)

  • 1. Structural biology of human cannabinoid receptor-2 helix 6 in membrane-mimetic environments.
    Tiburu EK; Tyukhtenko S; Deshmukh L; Vinogradova O; Janero DR; Makriyannis A
    Biochem Biophys Res Commun; 2009 Jun; 384(2):243-8. PubMed ID: 19397896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Cannabinoid Receptor 2 Ligand-Interaction Motif: Transmembrane Helix 2 Cysteine, C2.59(89), as Determinant of Classical Cannabinoid Agonist Activity and Binding Pose.
    Zhou H; Peng Y; Halikhedkar A; Fan P; Janero DR; Thakur GA; Mercier RW; Sun X; Ma X; Makriyannis A
    ACS Chem Neurosci; 2017 Jun; 8(6):1338-1347. PubMed ID: 28220706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR solution structure of human cannabinoid receptor-1 helix 7/8 peptide: candidate electrostatic interactions and microdomain formation.
    Tyukhtenko S; Tiburu EK; Deshmukh L; Vinogradova O; Janero DR; Makriyannis A
    Biochem Biophys Res Commun; 2009 Dec; 390(3):441-6. PubMed ID: 19766594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR structural comparison of the cytoplasmic juxtamembrane domains of G-protein-coupled CB1 and CB2 receptors in membrane mimetic dodecylphosphocholine micelles.
    Xie XQ; Chen JZ
    J Biol Chem; 2005 Feb; 280(5):3605-12. PubMed ID: 15550382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based proteomics of human cannabinoid receptor 2: covalent cysteine 6.47(257)-ligand interaction affording megagonist receptor activation.
    Szymanski DW; Papanastasiou M; Melchior K; Zvonok N; Mercier RW; Janero DR; Thakur GA; Cha S; Wu B; Karger B; Makriyannis A
    J Proteome Res; 2011 Oct; 10(10):4789-98. PubMed ID: 21861534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residues accessible in the binding-site crevice of transmembrane helix 6 of the CB2 cannabinoid receptor.
    Nebane NM; Hurst DP; Carrasquer CA; Qiao Z; Reggio PH; Song ZH
    Biochemistry; 2008 Dec; 47(52):13811-21. PubMed ID: 19053233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation.
    Pei Y; Mercier RW; Anday JK; Thakur GA; Zvonok AM; Hurst D; Reggio PH; Janero DR; Makriyannis A
    Chem Biol; 2008 Nov; 15(11):1207-19. PubMed ID: 19022181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding Site Characterization of AM1336, a Novel Covalent Inverse Agonist at Human Cannabinoid 2 Receptor, Using Mass Spectrometric Analysis.
    Mallipeddi S; Kreimer S; Zvonok N; Vemuri K; Karger BL; Ivanov AR; Makriyannis A
    J Proteome Res; 2017 Jul; 16(7):2419-2428. PubMed ID: 28374590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.
    Oh D; Shin SY; Lee S; Kang JH; Kim SD; Ryu PD; Hahm KS; Kim Y
    Biochemistry; 2000 Oct; 39(39):11855-64. PubMed ID: 11009597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D structural model of the G-protein-coupled cannabinoid CB2 receptor.
    Xie XQ; Chen JZ; Billings EM
    Proteins; 2003 Nov; 53(2):307-19. PubMed ID: 14517981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
    Pandey P; Roy KK; Doerksen RJ
    J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of peptides corresponding to the seven transmembrane domains of human adenosine A2a receptor.
    Lazarova T; Brewin KA; Stoeber K; Robinson CR
    Biochemistry; 2004 Oct; 43(40):12945-54. PubMed ID: 15461468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR characterization of recombinant transmembrane protein CB2 fragment CB2(180-233).
    Zhao J; Zheng H; Xie XQ
    Protein Pept Lett; 2006; 13(4):335-42. PubMed ID: 16712507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hCB2 ligand-interaction landscape: cysteine residues critical to biarylpyrazole antagonist binding motif and receptor modulation.
    Mercier RW; Pei Y; Pandarinathan L; Janero DR; Zhang J; Makriyannis A
    Chem Biol; 2010 Oct; 17(10):1132-42. PubMed ID: 21035736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic conformational responses of a human cannabinoid receptor-1 helix domain to its membrane environment.
    Tiburu EK; Gulla SV; Tiburu M; Janero DR; Budil DE; Makriyannis A
    Biochemistry; 2009 Jun; 48(22):4895-904. PubMed ID: 19485422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology modeling in tandem with 3D-QSAR analyses: a computational approach to depict the agonist binding site of the human CB2 receptor.
    Cichero E; Ligresti A; Allarà M; di Marzo V; Lazzati Z; D'Ursi P; Marabotti A; Milanesi L; Spallarossa A; Ranise A; Fossa P
    Eur J Med Chem; 2011 Sep; 46(9):4489-505. PubMed ID: 21835510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transmembrane helix-bundle from G-protein coupled receptor CB2: biosynthesis, purification, and NMR characterization.
    Zheng H; Zhao J; Sheng W; Xie XQ
    Biopolymers; 2006 Sep; 83(1):46-61. PubMed ID: 16634087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-Assisted Protein Structure (LAPS): An Experimental Paradigm for Characterizing Cannabinoid-Receptor Ligand-Binding Domains.
    Janero DR; Korde A; Makriyannis A
    Methods Enzymol; 2017; 593():217-235. PubMed ID: 28750804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of penetratin peptides. Part 1. The environment dependent conformational properties of penetratin and two of its derivatives.
    Czajlik A; Meskó E; Penke B; Perczel A
    J Pept Sci; 2002 Apr; 8(4):151-71. PubMed ID: 11991205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the cannabinoid CB1 receptor may involve a W6 48/F3 36 rotamer toggle switch.
    Singh R; Hurst DP; Barnett-Norris J; Lynch DL; Reggio PH; Guarnieri F
    J Pept Res; 2002 Dec; 60(6):357-70. PubMed ID: 12464114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.